August 3, 2016

Registration Statement Nos. 333-209682 and 333-209682-01; Rule 424(b)(8)

 https://cdn.kscope.io/83c0ffbfe48107527ffe237ed6ebfd12-Kwan's HD:Users:design:Documents:Kwan:JPM logos:J.P. Morgan Logos:Logo_2008_JPM_allSizes_RGB:PNG:Logo2008_JPM_C_RGB.png

JPMorgan Chase Financial Company LLC
Structured Investments

 

Contingent Buffered Equity Notes Linked to the Lesser Performing of the S&P 500® Index and the Russell 2000® Index due August 1, 2018

 

Fully and Unconditionally Guaranteed by JPMorgan Chase & Co.

 

Notwithstanding anything to the contrary set forth in pricing supplement no. 508 dated July 27, 2016 (the “pricing supplement”), the fees and commissions and the proceeds to issuer are as outlined in the chart below.

 

  Price to Public (1) Fees and Commissions (2) Proceeds to Issuer
Per note $1,000 $4 $996
Total $820,000 $3,280 $816,720

(1) See “Supplemental Use of Proceeds” in the pricing supplement for information about the components of the price to public of the notes.

 

(2) J.P. Morgan Securities LLC, which we refer to as JPMS, acting as agent for JPMorgan Financial, will pay all of the selling commissions of $4.00 per $1,000 principal amount note it receives from us to other affiliated or unaffiliated dealers. See “Plan of Distribution (Conflicts of Interest)” in the accompanying product supplement.

 

The estimated value of the notes, when the terms of the notes were set, was $983.10 per $1,000 principal amount note. See “The Estimated Value of the Notes” in the pricing supplement for additional information.

 

CUSIP: 46646EQS4

 

 

 

Investing in the notes involves a number of risks. See “Risk Factors” beginning on page PS-10 of the accompanying product supplement, “Risk Factors” beginning on page US-2 of the accompanying underlying supplement and “Selected Risk Considerations” beginning on page PS-3 of the pricing supplement.

 

Neither the Securities and Exchange Commission (the “SEC”) nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of the pricing supplement or the accompanying product supplement, underlying supplement, prospectus supplement and prospectus. Any representation to the contrary is a criminal offense.

 

The notes are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank

 

You should read this amendment together with pricing supplement no. 508 and the related product supplement, underlying supplement, prospectus supplement and prospectus, each of which can be accessed via the hyperlinks below. Please also see “Additional Terms Specific to the Notes” in the pricing supplement.

 

Pricing supplement no. 508 dated July 27, 2016:

http://www.sec.gov/Archives/edgar/data/19617/000095010316015160/dp67573_424b2-508.htm

 

Product supplement no. 4-I dated April 15, 2016:
http://www.sec.gov/Archives/edgar/data/19617/000095010316012644/crt_dp64831-424b2.pdf

 

Underlying supplement no. 1-I dated April 15, 2016:
http://www.sec.gov/Archives/edgar/data/19617/000095010316012649/crt-dp64909_424b2.pdf

 

Prospectus supplement and prospectus, each dated April 15, 2016:
http://www.sec.gov/Archives/edgar/data/19617/000095010316012636/crt_dp64952-424b2.pdf

 

Amendment no. 1 to pricing supplement no. 508 to product supplement no. 4-I dated April 15, 2016, underlying supplement no. 1-I dated April 15, 2016 and the prospectus and prospectus supplement, each dated April 15, 2016